For immediate release |
29 July 2010 |
Alliance Pharma plc
TR-1: Notification of major interests in shares
1. Identity of the issuer or the underlying issuer |
Alliance Pharma plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
Aviva plc & its subsidiaries |
|||
4. Full name of shareholder(s) |
Registered Holder:
BNY Norwich Union Nominees Limited 1,138,491*
Chase (GA Group) Nominees Limited 7,360,214*
CUIM Nominee Limited 2,770,404*
*denotes direct interest
BNP Paribas - London 2,237,424
Chase Nominees Limited 7,457,371
State Street Nominees Limited 2,352,851
|
|||
5. Date of the transaction and date on |
28 July 2010 |
|||
6. Date on which issuer notified: |
29 July 2010 |
|||
7. Threshold(s) that is/are crossed or |
<10% to 10% Change at Combined Interest Level |
|||
8. Notified details: |
|||||||||||
A: Voting rights attached to shares viii, ix |
|||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
|||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
|||||||
Ordinary Shares |
21,516,755 |
21,516,755 |
23,316,755 |
11,269,109 |
12,047,646 |
4.85% |
5.18% |
||||
|
|||||||||||
|
|||||||||||
B: Qualifying Financial Instruments |
|||||||||||
Resulting situation after the triggering transaction |
|||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|||||||
|
|
|
|
|
|||||||
|
|||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||
Resulting situation after the triggering transaction |
||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
|
|
|
|
|
|
Nominal |
Delta |
|
|
|||||
Total (A+B+C) |
||||||
Number of voting rights |
Percentage of voting rights |
|||||
23,316,755 |
10.03% |
9. Chain of controlled undertakings through which the voting rights and/or the |
||
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
See Section 4 |
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
|
|
14. Contact name: |
Diane Thirkettle |
|
15. Contact telephone number: |
01603 687803 |
|